Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01352195 · ClinicalTrials.gov registry record · NA
Extended Self-Help for Smoking Cessation
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,124
- Enrollment target
NCT01352195: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT01352195 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 2,124 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01352195, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,124 participants
- Enrollment target
Study Summary
The primary purpose of this study is smoking cessation. The investigators are conducting a research study to learn how well the information from the program helps participants to quit smoking and remain smoke-free.
Primary Outcome
Time will be measured in months from the start of condition. Potential confounding variables (e.g., group differences in demographic, smoking history, or pharmacotherapy use) will be adjusted for in the model. Pair-wise condition and time interval comparisons will be tested using the generalized score statistics from generalized estimating equations (GEE) models by utilizing the contrast statements.
Interventions
- BEHAVIORAL Forever Free Booklets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,124 participants |
| Start Date | 2009-01-23 |
| Est. Completion | 2014-08-27 |
| Phase | NA |
What the finished NCT01352195 record still lists
NCT01352195 is an interventional study that assigns participants to a tested intervention. Its 2,124 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% higher).
The record links to 0 conditions, and to 1 intervention - of which Forever Free Booklets is the first listed.
NCT01352195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01352195 about?
NCT01352195 is a clinical study titled "Extended Self-Help for Smoking Cessation". The primary purpose of this study is smoking cessation. The investigators are conducting a research study to learn how well the information from the program helps participants to quit smoking and remain smoke-free.
What is the current status of trial NCT01352195?
This trial is currently completed. It is a NA study. The enrollment target is 2,124 participants. The study started on 2009-01-23. Estimated completion is 2014-08-27.
What interventions are being tested in trial NCT01352195?
The interventions under investigation include: Forever Free Booklets (BEHAVIORAL).
Who is sponsoring clinical trial NCT01352195?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01352195's enrollment target sits among peer trials
2,124 49th of 2000 higher than 1,952 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05681624 · 2,124 participants · NA
Maternal Oxygen Supplementation for Intrauterine Resuscitation
- NCT05916430 · 2,120 participants
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- NCT05650658 · 2,136 participants · NA
Left vs Left Randomized Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI